Company: SNWV
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001628280-25-023881
Chunk: 41

Company: SANUWAVE Health, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 41
---
standing, December 31, 20241,137 $15.97 9.5$9,305 Granted176 27.42 7.81,393 Forfeited(80)0.0- Outstanding, March 31, 20251,233 $17.37 9.1$22,883 Exercisable, March 31, 2025207 $21.82 7.5$3,499 

17

Valuation Information for Stock-Based CompensationThe fair value of each stock option award during the three months ended March 31, 2025 was based on the closing price of the Company's common stock on the date of the grant. Expected volatility was based on 100% of the historical realized volatilities of peer companies. The risk-free interest rate was based on the implied yield for U.S. Treasury zero-coupon issue with the remaining term equal to the expected term. The expected holding period was calculated using the simplified method. No dividend was assumed as the Company does not pay regular dividends on its common stock and does not anticipate paying any dividends in the foreseeable future. The Company's policy is to recognize forfeitures as they occur.The weighted average assumptions used in the Black-Scholes option pricing model in valuing stock options granted in the three months ended March 31, 2025 are summarized in the table below:Three Months Ended March 31,2025Fair value at grant date$27.47Expected volatility62%Risk-free interest rate4%Expected holding period, in years5.45Dividend yield0%

14.       Loss per Share

Basic net loss per share is calculated by dividing the net loss attributable to common stockholders by the weighted average number of shares outstanding for the three months ended March 31, 2025, and 2024. The weighted average number of shares outstanding includes outstanding common stock and shares issuable for nominal consideration. Accordingly, warrants issued with a $0.01 per share exercise price, are included in weighted average shares outstanding as follows:Three Months Ended(in thousands)March 31, 2025March 31, 2024Weighted average shares outstandingCommon shares8,548 3,041 Common shares issuable assuming exercise of nominally priced warrants- 58 Weighted average shares outstanding8,548 3,099 Diluted net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted